基层医疗机构的抗精神病药物管理:基于人群的纵向研究

Alan Woodall, Alex Gampel, Huw Collins, Lauren E Walker, Frances S Mair, Sally B Sheard, Pyers Symon, Iain Buchan
{"title":"基层医疗机构的抗精神病药物管理:基于人群的纵向研究","authors":"Alan Woodall, Alex Gampel, Huw Collins, Lauren E Walker, Frances S Mair, Sally B Sheard, Pyers Symon, Iain Buchan","doi":"10.1101/2024.06.18.24309122","DOIUrl":null,"url":null,"abstract":"Background: The use of antipsychotics in primary care is increasing, and more are being used for non-psychotic illnesses. Long-term use of antipsychotics confers increased risk of cardiometabolic disease, so ongoing need should be reviewed regularly by psychiatrists. This study explored changes over time in antipsychotic management and prescribing in primary care, and proportions of patients (≥18 years) prescribed antipsychotics receiving psychiatrist review. Methods and Findings: This was a retrospective, population-based observational study using data from the Secure Anonymised Information Linkage databank of approximately 3 million people in Wales (2011 to 2020). Outcomes were prevalence of patients who had received ≥6 antipsychotic prescriptions per year, proportion of patients prescribed antipsychotics who had received psychiatrist review in the preceding 12 months, and proportion of patients prescribed antipsychotics who were registered on the UK Primary Care Serious Mental Illness, Depression and/or Dementia registers, or were not on these registers. The prevalence of adults prescribed antipsychotics increased from 1.06% (95%CI 1.04 to 1.07%) in 2011 to 1.45% (95%CI 1.43 to 1.46%) in 2020; 1 in 69 adults were prescribed antipsychotics in 2020. The proportion of adults taking antipsychotics solely managed by primary care increased from 40% (95%CI 39 to 41%) in 2011 to 48% (95%CI 47 to 49%) by 2020. The proportion of antipsychotics prescribed to patients not on the Serious Mental Illness register increased from 50% (95%CI 49 to 51%) in 2011 to 56% (95%CI 56 to 57%) by 2020, meaning many patients may not be monitored for the cardiometabolic risk from antipsychotics. Conclusions: Antipsychotic prescribing is increasing. More people are solely managed by general practitioners without psychiatrist review and are not on relevant disease registers, so are less are likely to undergo vital cardiometabolic monitoring. These trends pose risks for patients and need to be addressed urgently.","PeriodicalId":501023,"journal":{"name":"medRxiv - Primary Care Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antipsychotic management in primary care: a longitudinal population-based study\",\"authors\":\"Alan Woodall, Alex Gampel, Huw Collins, Lauren E Walker, Frances S Mair, Sally B Sheard, Pyers Symon, Iain Buchan\",\"doi\":\"10.1101/2024.06.18.24309122\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: The use of antipsychotics in primary care is increasing, and more are being used for non-psychotic illnesses. Long-term use of antipsychotics confers increased risk of cardiometabolic disease, so ongoing need should be reviewed regularly by psychiatrists. This study explored changes over time in antipsychotic management and prescribing in primary care, and proportions of patients (≥18 years) prescribed antipsychotics receiving psychiatrist review. Methods and Findings: This was a retrospective, population-based observational study using data from the Secure Anonymised Information Linkage databank of approximately 3 million people in Wales (2011 to 2020). Outcomes were prevalence of patients who had received ≥6 antipsychotic prescriptions per year, proportion of patients prescribed antipsychotics who had received psychiatrist review in the preceding 12 months, and proportion of patients prescribed antipsychotics who were registered on the UK Primary Care Serious Mental Illness, Depression and/or Dementia registers, or were not on these registers. The prevalence of adults prescribed antipsychotics increased from 1.06% (95%CI 1.04 to 1.07%) in 2011 to 1.45% (95%CI 1.43 to 1.46%) in 2020; 1 in 69 adults were prescribed antipsychotics in 2020. The proportion of adults taking antipsychotics solely managed by primary care increased from 40% (95%CI 39 to 41%) in 2011 to 48% (95%CI 47 to 49%) by 2020. The proportion of antipsychotics prescribed to patients not on the Serious Mental Illness register increased from 50% (95%CI 49 to 51%) in 2011 to 56% (95%CI 56 to 57%) by 2020, meaning many patients may not be monitored for the cardiometabolic risk from antipsychotics. Conclusions: Antipsychotic prescribing is increasing. More people are solely managed by general practitioners without psychiatrist review and are not on relevant disease registers, so are less are likely to undergo vital cardiometabolic monitoring. These trends pose risks for patients and need to be addressed urgently.\",\"PeriodicalId\":501023,\"journal\":{\"name\":\"medRxiv - Primary Care Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Primary Care Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.06.18.24309122\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Primary Care Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.06.18.24309122","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:抗精神病药物在初级保健中的使用正在增加,而且越来越多地用于非精神病性疾病。长期使用抗精神病药物会增加罹患心脏代谢疾病的风险,因此精神科医生应定期检查是否需要继续使用。本研究探讨了基层医疗机构抗精神病药物管理和处方随时间推移而发生的变化,以及处方抗精神病药物的患者(≥18 岁)接受精神科医生复查的比例。方法和结果:这是一项基于人群的回顾性观察研究,使用的数据来自安全匿名信息链接数据库,涉及威尔士约 300 万人口(2011 年至 2020 年)。研究结果包括每年接受过≥6次抗精神病药物处方的患者比例、在过去12个月中接受过精神科医生复查的抗精神病药物处方患者比例,以及在英国初级医疗严重精神疾病、抑郁症和/或痴呆症登记册上登记或未登记的抗精神病药物处方患者比例。开具抗精神病药物处方的成人患病率从2011年的1.06%(95%CI为1.04%至1.07%)增至2020年的1.45%(95%CI为1.43%至1.46%);2020年,每69名成人中就有1人开具抗精神病药物处方。完全由基层医疗机构管理的服用抗精神病药物的成人比例从2011年的40%(95%CI为39%至41%)增加到2020年的48%(95%CI为47%至49%)。为未列入严重精神疾病登记册的患者开具抗精神病药物处方的比例从2011年的50%(95%CI为49%至51%)增加到2020年的56%(95%CI为56%至57%),这意味着许多患者可能无法监测到抗精神病药物带来的心脏代谢风险。结论抗精神病药物的处方量正在增加。越来越多的人只接受全科医生的管理,没有经过精神科医生的审查,也不在相关疾病登记册上,因此不太可能接受重要的心脏代谢监测。这些趋势给患者带来了风险,亟待解决。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Antipsychotic management in primary care: a longitudinal population-based study
Background: The use of antipsychotics in primary care is increasing, and more are being used for non-psychotic illnesses. Long-term use of antipsychotics confers increased risk of cardiometabolic disease, so ongoing need should be reviewed regularly by psychiatrists. This study explored changes over time in antipsychotic management and prescribing in primary care, and proportions of patients (≥18 years) prescribed antipsychotics receiving psychiatrist review. Methods and Findings: This was a retrospective, population-based observational study using data from the Secure Anonymised Information Linkage databank of approximately 3 million people in Wales (2011 to 2020). Outcomes were prevalence of patients who had received ≥6 antipsychotic prescriptions per year, proportion of patients prescribed antipsychotics who had received psychiatrist review in the preceding 12 months, and proportion of patients prescribed antipsychotics who were registered on the UK Primary Care Serious Mental Illness, Depression and/or Dementia registers, or were not on these registers. The prevalence of adults prescribed antipsychotics increased from 1.06% (95%CI 1.04 to 1.07%) in 2011 to 1.45% (95%CI 1.43 to 1.46%) in 2020; 1 in 69 adults were prescribed antipsychotics in 2020. The proportion of adults taking antipsychotics solely managed by primary care increased from 40% (95%CI 39 to 41%) in 2011 to 48% (95%CI 47 to 49%) by 2020. The proportion of antipsychotics prescribed to patients not on the Serious Mental Illness register increased from 50% (95%CI 49 to 51%) in 2011 to 56% (95%CI 56 to 57%) by 2020, meaning many patients may not be monitored for the cardiometabolic risk from antipsychotics. Conclusions: Antipsychotic prescribing is increasing. More people are solely managed by general practitioners without psychiatrist review and are not on relevant disease registers, so are less are likely to undergo vital cardiometabolic monitoring. These trends pose risks for patients and need to be addressed urgently.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信